Literature DB >> 7925662

Toxin production, adherence and protein expression by clinical Aeromonas spp. isolates in broth and human pooled ileostomy fluid.

M H Wilcox1, A Cook, I Geary, A Eley.   

Abstract

The physiological behaviour of clinical Aeromonas spp. isolates was compared following culture in a conventional broth and human pooled ileostomy fluid (PIF). Protein expression was markedly affected by the growth medium, with an overall reduction in whole cell proteins in bacteria grown in ileostomy fluid. In addition, novel outer membrane proteins were produced in PIF but not in broth. The majority of A. hydrophila and A. sobria isolates produced toxin in both broth and PIF, whereas no cytotoxin positive A. caviae were found. Toxin titres were at least two doubling dilutions higher in 40% and 21% of A. hydrophila and A. sobria isolates, respectively, following culture in brain heart infusion broth compared with PIF. Bacterial adherence to Vero and A-549 cells was significantly more common in A. hydrophila (53%) and A. sobria (64%) than in A. caviae (15%) (P < 0.01). We observed increased adherence by 6 aeromonas strains previously classified as adherence-positive, but not by 6 non-adherers, in PIF compared with brain heart infusion broth. The influence of growth medium on the expression of potential virulence determinants by Aeromonas spp. provides a rationale for the use of human ileostomy fluid in future in vitro studies, in order to simulate the nutrient conditions found in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925662      PMCID: PMC2271534          DOI: 10.1017/s0950268800051669

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  23 in total

1.  Bacterial growth and toxin production in ileostomy effluents.

Authors:  D A Ala Aldeen; M R Barer
Journal:  J Med Microbiol       Date:  1989-04       Impact factor: 2.472

Review 2.  The influence of environment on envelope properties affecting survival of bacteria in infections.

Authors:  M R Brown; P Williams
Journal:  Annu Rev Microbiol       Date:  1985       Impact factor: 15.500

3.  Use of A-549 cells in a clinical virology laboratory.

Authors:  G L Woods; A Young
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

4.  Adhesion of clinical and environmental Aeromonas isolates to HEp-2 cells.

Authors:  A Carrello; K A Silburn; J R Budden; B J Chang
Journal:  J Med Microbiol       Date:  1988-05       Impact factor: 2.472

Review 5.  Mesophilic aeromonads in human disease: current taxonomy, laboratory identification, and infectious disease spectrum.

Authors:  J M Janda; P S Duffey
Journal:  Rev Infect Dis       Date:  1988 Sep-Oct

6.  Toxin production by Aeromonas spp. from different sources.

Authors:  S E Millership; M R Barer; S Tabaqchali
Journal:  J Med Microbiol       Date:  1986-12       Impact factor: 2.472

7.  Invasiveness of Aeromonas spp. in relation to biotype, virulence factors, and clinical features.

Authors:  I M Watson; J O Robinson; V Burke; M Gracey
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

8.  Suicide phenomenon in mesophilic aeromonads as a basis for species identification.

Authors:  H Namdari; E J Bottone
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

9.  The microbiology of childhood gastroenteritis: Aeromonas species and other infective agents.

Authors:  V Burke; M Gracey; J Robinson; D Peck; J Beaman; C Bundell
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

10.  Adherence to HEp-2 cells and enteropathogenic potential of Aeromonas spp.

Authors:  P A Grey; S M Kirov
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.